Press Releases

Bothell, WA – FUJIFILM Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – is now the exclusive ultrasound sponsor of The Resuscitative Transesophageal Echocardiography (TEE) Workshop, a prominent and globally active clinical education programme presented by a multidisciplinary team of leaders in this emerging ultrasound modality. The Resuscitative TEE Workshop is an eight-hour practical and multidisciplinary course intended to provide clinicians with the fundamental knowledge and skills necessary to perform focused TEE with critically ill patients in any acute care setting.

“The use of transesophageal ultrasound (TEU) is expanding rapidly as demonstrated by the increasing use of the sub-modality TEE for resuscitation,” said FUJIFILM Sonosite President and CEO Rich Fabian. “As the company that created the POCUS category, we are committed to helping our clinician partners and customers advance along with the technology by providing ongoing educational opportunities that help improve patient care.”

Using...

Sonosite LX combines the company’s largest clinical image yet with proprietary advanced image clarity to deliver greater diagnostic and procedural confidence, along with an adjustable monitor and touchscreen interface to improve collaboration

Bothell, WA, – FUJIFILM Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – has added to its next-generation POCUS portfolio with the launch of its new, premium Sonosite LX system, featuring the company’s largest clinical image and a monitor that extends, rotates and tilts to enable enhanced, real-time provider collaboration. The clinical display features touchscreen controls to enable an optimised heads-up workflow, allowing clinicians to keep their eyes on the image while making adjustments.

Designed to be used with the Sonosite LX and Sonosite PX, the company has also launched a new T8-3 transesophageal transducer and Cardiac Resuscitation exam type, to assist clinicians in using transesophageal ultrasound (TEU) at the point of...

Clinicians will help investigate the role of point-of-care ultrasound (POCUS) technology in patients with COVID-19.

Bothell, WA — FUJIFILM Sonosite, Inc. , the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation , the charitable foundation of the American College of Chest Physicians , announced two recipients of the CHEST Foundation’s Research Grant in Ultrasonography and COVID-19 today. The grants include $30,000 in support and FUJIFILM Sonosite’s newly launched Sonosite PX ultrasound system for the study of POCUS efficacy in diagnosing and treating COVID-19 patients in the intensive care unit (ICU).

As of late- January 2021 , COVID-19 has claimed over 2.1 million lives and infected well over 100 million people across the world. Initial studies report that POCUS’ real-time imaging, mobility and multiple uses provides clinicians with a technology that could be used for the diagnosis, treatment and follow-up care of patients...

Bothell, WA – September 3, 2020 — FUJIFILM Sonosite, Inc. , specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, today announced that the company has received 510(k) Clearance from the U.S. Food & Drug Administration (FDA) for the company’s entire POCUS portfolio to support healthcare providers in performing accurate lung and cardiac imaging in COVID-19 patients.

Fujifilm Sonosite creates point-of-care ultrasound systems and medical informatics solutions along with transducers and accessories that can help physicians improve time-to-diagnosis, patient outcomes, procedural efficiency, and workflow.

“POCUS has emerged as a critical tool to support clinicians in their tireless efforts to evaluate lung and cardiac complications of COVID-19,” said Diku Mandavia, MD, FACEP, FRCPC, Senior Vice President and Chief Medical Officer of FUJIFILM Sonosite, Inc. “We’re very pleased that Fujifilm Sonosite’s POCUS portfolio has received this clearance from the FDA and most...